C4 Therapeutics Stock Price History
| CCCC Stock | USD 2.32 0.14 6.42% |
Below is the normalized historical share price chart for C4 Therapeutics extending back to October 02, 2020. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of C4 Therapeutics stands at 2.32, as last reported on the 20th of July, with the highest price reaching 2.71 and the lowest price hitting 2.23 during the day.
If you're considering investing in CCCC Stock, it is important to understand the factors that can impact its price. C4 Therapeutics is risky given 3 months investment horizon. C4 Therapeutics retains Efficiency (Sharpe Ratio) of 0.15, which signifies that the company had a 0.15 % return per unit of price deviation over the last 3 months. We were able to break down thirty different technical indicators, which can help you to evaluate if expected returns of 1.02% are justified by taking the suggested risk. Use C4 Therapeutics Standard Deviation of 6.94, coefficient of variation of 579.74, and Market Risk Adjusted Performance of 0.7323 to evaluate company specific risk that cannot be diversified away. At present, C4 Therapeutics' Issuance Of Capital Stock is projected to increase significantly based on the last few years of reporting. . At present, C4 Therapeutics' Price Earnings To Growth Ratio is projected to slightly decrease based on the last few years of reporting. The current year's Price To Book Ratio is expected to grow to 1.21, whereas Price To Sales Ratio is forecasted to decline to 6.67. CCCC Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 2nd of October 2020 | 200 Day MA 3.0901 | 50 Day MA 1.5898 | Beta 2.946 |
Sharpe Ratio = 0.1527
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | CCCC | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 6.68 actual daily | 59 59% of assets are less volatile |
Expected Return
| 1.02 actual daily | 20 80% of assets have higher returns |
Risk-Adjusted Return
| 0.15 actual daily | 12 88% of assets perform better |
Based on monthly moving average C4 Therapeutics is performing at about 12% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of C4 Therapeutics by adding it to a well-diversified portfolio.
Price Book 0.8442 | Enterprise Value Ebitda (0.42) | Price Sales 4.1409 | Shares Float 49.7 M | Wall Street Target Price 15.8 |
C4 Therapeutics Stock Price History Chart
There are several ways to analyze CCCC Stock price data. The simplest method is using a basic CCCC candlestick price chart, which shows C4 Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | July 14, 2025 | 2.38 |
| Lowest Price | May 30, 2025 | 1.25 |
C4 Therapeutics July 20, 2025 Stock Price Synopsis
Various analyses of C4 Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell CCCC Stock. It can be used to describe the percentage change in the price of C4 Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of CCCC Stock.| C4 Therapeutics Price Action Indicator | (0.08) | |
| C4 Therapeutics Price Rate Of Daily Change | 1.06 | |
| C4 Therapeutics Price Daily Balance Of Power | 0.29 |
C4 Therapeutics July 20, 2025 Stock Price Analysis
CCCC Stock Price History Data
The price series of C4 Therapeutics for the period between Mon, Apr 21, 2025 and Sun, Jul 20, 2025 has a statistical range of 1.28 with a coefficient of variation of 16.74. The prices are distributed with arithmetic mean of 1.56. The median price for the last 90 days is 1.52.| Open | High | Low | Close | Volume | ||
07/20/2025 | 2.24 | 2.71 | 2.23 | 2.32 | ||
07/18/2025 | 2.24 | 2.71 | 2.23 | 2.32 | 3,476,011 | |
07/17/2025 | 1.97 | 2.26 | 1.95 | 2.18 | 1,119,792 | |
07/16/2025 | 2.14 | 2.22 | 2.01 | 2.02 | 1,281,704 | |
07/15/2025 | 2.38 | 2.39 | 2.10 | 2.11 | 1,698,965 | |
07/14/2025 | 2.23 | 2.40 | 2.14 | 2.38 | 2,435,939 | |
| 07/11/2025 | 1.97 | 2.41 | 1.93 | 2.23 | 4,061,023 | |
07/10/2025 | 2.02 | 2.04 | 1.89 | 1.99 | 1,328,133 | |
07/09/2025 | 1.74 | 2.17 | 1.73 | 2.02 | 3,466,700 | |
07/08/2025 | 1.53 | 1.80 | 1.53 | 1.71 | 1,567,005 | |
07/07/2025 | 1.47 | 1.53 | 1.44 | 1.52 | 569,556 | |
07/03/2025 | 1.54 | 1.56 | 1.44 | 1.48 | 725,793 | |
07/02/2025 | 1.50 | 1.53 | 1.43 | 1.52 | 1,751,486 | |
| 07/01/2025 | 1.40 | 1.60 | 1.40 | 1.51 | 1,068,200 | |
06/30/2025 | 1.42 | 1.48 | 1.40 | 1.43 | 677,370 | |
06/27/2025 | 1.53 | 1.55 | 1.40 | 1.40 | 5,771,133 | |
06/26/2025 | 1.54 | 1.56 | 1.47 | 1.52 | 676,705 | |
06/25/2025 | 1.56 | 1.57 | 1.48 | 1.54 | 471,380 | |
06/24/2025 | 1.51 | 1.63 | 1.49 | 1.56 | 941,900 | |
06/23/2025 | 1.42 | 1.47 | 1.36 | 1.47 | 801,576 | |
06/20/2025 | 1.45 | 1.46 | 1.38 | 1.42 | 1,056,829 | |
| 06/18/2025 | 1.49 | 1.54 | 1.43 | 1.44 | 971,900 | |
06/17/2025 | 1.61 | 1.62 | 1.48 | 1.49 | 945,174 | |
06/16/2025 | 1.69 | 1.74 | 1.60 | 1.63 | 982,359 | |
06/13/2025 | 1.56 | 1.71 | 1.53 | 1.68 | 1,372,300 | |
06/12/2025 | 1.49 | 1.62 | 1.43 | 1.62 | 1,215,272 | |
06/11/2025 | 1.57 | 1.60 | 1.49 | 1.52 | 996,063 | |
06/10/2025 | 1.69 | 1.72 | 1.53 | 1.57 | 1,655,500 | |
| 06/09/2025 | 1.78 | 1.78 | 1.61 | 1.68 | 991,888 | |
06/06/2025 | 1.50 | 1.75 | 1.50 | 1.73 | 1,280,800 | |
06/05/2025 | 1.52 | 1.53 | 1.43 | 1.47 | 766,056 | |
06/04/2025 | 1.47 | 1.57 | 1.47 | 1.54 | 564,958 | |
06/03/2025 | 1.36 | 1.52 | 1.31 | 1.48 | 1,060,476 | |
06/02/2025 | 1.27 | 1.43 | 1.27 | 1.33 | 1,223,085 | |
05/30/2025 | 1.29 | 1.29 | 1.21 | 1.25 | 834,438 | |
05/29/2025 | 1.28 | 1.35 | 1.25 | 1.32 | 1,027,400 | |
05/28/2025 | 1.31 | 1.31 | 1.24 | 1.26 | 774,409 | |
05/27/2025 | 1.42 | 1.43 | 1.28 | 1.30 | 839,300 | |
| 05/23/2025 | 1.36 | 1.38 | 1.32 | 1.38 | 453,300 | |
05/22/2025 | 1.41 | 1.42 | 1.35 | 1.37 | 632,776 | |
05/21/2025 | 1.46 | 1.48 | 1.33 | 1.36 | 945,206 | |
05/20/2025 | 1.52 | 1.54 | 1.45 | 1.48 | 688,603 | |
05/19/2025 | 1.34 | 1.58 | 1.34 | 1.54 | 2,273,939 | |
05/16/2025 | 1.39 | 1.42 | 1.34 | 1.38 | 1,276,500 | |
05/15/2025 | 1.37 | 1.39 | 1.30 | 1.38 | 620,905 | |
05/14/2025 | 1.49 | 1.49 | 1.36 | 1.37 | 679,510 | |
05/13/2025 | 1.62 | 1.62 | 1.47 | 1.50 | 909,719 | |
05/12/2025 | 1.52 | 1.64 | 1.52 | 1.58 | 979,700 | |
05/09/2025 | 1.53 | 1.63 | 1.45 | 1.47 | 1,168,878 | |
05/08/2025 | 1.53 | 1.61 | 1.42 | 1.54 | 1,056,500 | |
| 05/07/2025 | 1.56 | 1.68 | 1.46 | 1.50 | 2,351,377 | |
05/06/2025 | 1.59 | 1.59 | 1.40 | 1.41 | 1,060,442 | |
05/05/2025 | 1.70 | 1.72 | 1.61 | 1.62 | 520,230 | |
05/02/2025 | 1.65 | 1.79 | 1.65 | 1.74 | 1,142,815 | |
05/01/2025 | 1.63 | 1.66 | 1.55 | 1.63 | 563,500 | |
04/30/2025 | 1.56 | 1.65 | 1.48 | 1.64 | 506,545 | |
04/29/2025 | 1.61 | 1.64 | 1.56 | 1.58 | 410,286 | |
04/28/2025 | 1.57 | 1.67 | 1.53 | 1.62 | 1,090,300 | |
04/25/2025 | 1.60 | 1.64 | 1.49 | 1.54 | 1,277,900 | |
04/24/2025 | 1.64 | 1.64 | 1.51 | 1.61 | 1,314,000 | |
04/23/2025 | 1.60 | 1.74 | 1.56 | 1.61 | 3,659,418 |
About C4 Therapeutics Stock history
C4 Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for CCCC is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in C4 Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing C4 Therapeutics stock prices may prove useful in developing a viable investing in C4 Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 69.4 M | 53.8 M | |
| Net Loss | -115.4 M | -109.6 M |
C4 Therapeutics Quarterly Net Working Capital |
|
C4 Therapeutics Stock Technical Analysis
C4 Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Price Transformation Now
Price TransformationUse Price Transformation models to analyze the depth of different equity instruments across global markets |
| All Next | Launch Module |
C4 Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for C4 Therapeutics' price direction in advance. Along with the technical and fundamental analysis of CCCC Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of CCCC to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1698 | |||
| Jensen Alpha | 0.9728 | |||
| Total Risk Alpha | 0.2155 | |||
| Sortino Ratio | 0.1817 | |||
| Treynor Ratio | 0.7223 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for CCCC Stock analysis
When running C4 Therapeutics' price analysis, check to measure C4 Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy C4 Therapeutics is operating at the current time. Most of C4 Therapeutics' value examination focuses on studying past and present price action to predict the probability of C4 Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move C4 Therapeutics' price. Additionally, you may evaluate how the addition of C4 Therapeutics to your portfolios can decrease your overall portfolio volatility.
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |